Single Convention on Narcotic Drugs

From WikiMD's WELLNESSPEDIA

Single Convention on Narcotic Drugs is an international treaty that aims to prohibit production and supply of specific narcotic drugs and drugs with similar effects except for medical and scientific purposes. It was established in 1961 and is overseen by the United Nations.

History[edit]

The Single Convention on Narcotic Drugs was established in 1961 as a result of a merger of several international drug control treaties dating back to the 1920s. The Convention was designed to combat drug abuse by coordinated international action. It seeks to limit the possession, use, trade, distribution, import, export, manufacture and production of drugs exclusively to medical and scientific purposes.

Provisions[edit]

The Single Convention on Narcotic Drugs has several key provisions. It categorizes drugs into four schedules, with varying degrees of control. Schedule I drugs are subject to the highest level of control, while Schedule IV drugs are subject to the least. The Convention also establishes a International Narcotics Control Board to oversee and control the cultivation of plants used in the production of narcotics.

Criticisms[edit]

Despite its intentions, the Single Convention on Narcotic Drugs has been criticized for its approach to drug control. Critics argue that it has led to the criminalization of drug users and has not effectively reduced drug use or the illicit drug trade.

See also[edit]

Single_Convention_on_Narcotic_Drugs[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.